Tenax Therapeutics (TENX) Proxy filing summary

Voting matters and shareholder proposals

• Shareholders will vote on the election of seven director nominees for the board, including June Almenoff, Michael Davidson, Declan Doogan, Christopher Giordano, Robyn Hunter, Gerald Proehl, and Stuart Rich.

• Ratification of Cherry Bekaert LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is on the agenda.

• The proxy may vote on other business that may properly come before the meeting or any adjournment.

Board of directors and corporate governance

• Seven individuals are nominated for election to the board, representing a mix of medical, executive, and financial expertise.

Audit committee and external auditor matters

• Cherry Bekaert LLP is recommended for ratification as the independent registered public accounting firm for the next fiscal year.